Literature DB >> 22213314

Determination of 1,25-dihydroxyvitamin D concentrations in human colon tissues and matched serum samples.

Dennis Wagner1, Andre G Dias, Kareena Schnabl, Theodorus Van der Kwast, Reinhold Vieth.   

Abstract

BACKGROUND: A novel method to measure 1,25-dihydroxyvitamin D (1,25(OH)(2)D) in human tissue was developed and validated. The objectives of this study were to determine whether 1,25(OH)(2)D is present in human colon tissue and to characterize the relationship between human colon tissue and serum 1,25(OH)(2)D concentrations.
MATERIALS AND METHODS: Normal colon tissue specimens and matched serum samples were obtained from 30 patients who had undergone colectomy. Colon 1,25(OH)(2)D was measured by lipid extraction followed by enzyme immunoassay (EIA). Serum 1,25(OH)(2)D and 25-hydroxyvitamin D (25(OH)D) were measured by EIA. Vitamin D binding protein (DBP) was measured in a subset of serum and tissue samples.
RESULTS: Regression analysis indicated a significant positive correlation between serum and colon 1,25(OH)(2)D concentrations (r=0.58, p=0.0008). The corresponding intercept at zero serum 1,25(OH)(2)D was 21.5 pmol/kg (95% CI=16.95-25.98; p<0.001). Colon 1,25(OH)(2)D did not correlate significantly with serum 25(OH)D. DBP levels in tissue samples were negligible.
CONCLUSION: The hormone 1,25(OH)(2)D can be successfully detected in human colon at physiologically relevant concentrations, partly determined by serum 1,25(OH)(2)D. The results support the notion of in vivo synthesis of 1,25(OH)(2)D within colon tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213314

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

2.  High-dose vitamin D3 supplementation decreases the number of colonic CD103+ dendritic cells in healthy subjects.

Authors:  Nina Friis Bak; M Bendix; S Hald; L Reinert; M K Magnusson; J Agnholt
Journal:  Eur J Nutr       Date:  2017-09-14       Impact factor: 5.614

3.  Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.

Authors:  Angeline A Giangreco; Avani Vaishnav; Dennis Wagner; Antonio Finelli; Neil Fleshner; Theodorus Van der Kwast; Reinhold Vieth; Larisa Nonn
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-15

4.  Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial.

Authors:  Petr Protiva; Swaroop Pendyala; Celeste Nelson; Leonard H Augenlicht; Martin Lipkin; Peter R Holt
Journal:  Am J Clin Nutr       Date:  2016-03-23       Impact factor: 7.045

Review 5.  Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.

Authors:  Julia Höbaus; Ursula Thiem; Doris M Hummel; Enikö Kallay
Journal:  Anticancer Agents Med Chem       Date:  2013-01       Impact factor: 2.505

6.  Intestinal Phosphorus Absorption in Moderate CKD and Healthy Adults Determined Using a Radioisotopic Tracer.

Authors:  Elizabeth R Stremke; Gretchen N Wiese; Sharon M Moe; Meryl E Wastney; Ranjani N Moorthi; Kathleen M Hill Gallant
Journal:  J Am Soc Nephrol       Date:  2021-07-08       Impact factor: 14.978

7.  Maternal vitamin D, DNA methylation at imprint regulatory regions and offspring weight at birth, 1 year and 3 years.

Authors:  S E Benjamin Neelon; A J White; A C Vidal; J M Schildkraut; A P Murtha; S K Murphy; S W Kullman; C Hoyo
Journal:  Int J Obes (Lond)       Date:  2017-07-05       Impact factor: 5.095

8.  Oral vitamin D supplementation induces transcriptomic changes in rectal mucosa that are linked to anti-tumour effects.

Authors:  P G Vaughan-Shaw; G Grimes; J P Blackmur; M Timofeeva; M Walker; L Y Ooi; Victoria Svinti; Kevin Donnelly; F V N Din; S M Farrington; M G Dunlop
Journal:  BMC Med       Date:  2021-08-03       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.